Literature DB >> 18041755

Pulmonary function in adolescents with ataxia telangiectasia.

Sharon McGrath-Morrow1, Maureen Lefton-Greif, Karen Rosquist, Thomas Crawford, Amber Kelly, Pamela Zeitlin, Kathryn A Carson, Howard M Lederman.   

Abstract

INTRODUCTION: Pulmonary complications are common in adolescents with ataxia telangiectasia (A-T), however objective measurements of lung function may be difficult to obtain because of underlying bulbar weakness, tremors, and difficulty coordinating voluntary respiratory maneuvers. To increase the reliability of pulmonary testing, minor adjustments were made to stabilize the head and to minimize leaks in the system. Fifteen A-T adolescents completed lung volume measurements by helium dilution. To assess for reproducibility of spirometry testing, 10 A-T adolescents performed spirometry on three separate occasions.
RESULTS: Total lung capacity (TLC) was normal or just mildly decreased in 12/15 adolescents tested. TLC correlated positively with functional residual capacity (FRC), a measurement independent of patient effort (R2=0.71). The majority of individuals had residual volumes (RV) greater than 120% predicted (10/15) and slow vital capacities (VC) less than 70% predicted (9/15). By spirometry, force vital capacity (FVC) and forced expiratory volume in 1 sec (FEV1) values were reproducible in the 10 individuals who underwent testing on three separate occasions (R=0.97 and 0.96 respectively). Seven of the 10 adolescents had FEV1/FVC ratios>90%.
CONCLUSION: Lung volume measurements from A-T adolescents revealed near normal TLC values with increased RV and decreased VC values. These findings indicate a decreased ability to expire to residual volume rather then a restrictive defect. Spirometry was also found to be reproducible in A-T adolescents suggesting that spirometry testing may be useful for tracking changes in pulmonary function over time in this population. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18041755     DOI: 10.1002/ppul.20738

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  9 in total

1.  Evaluation and management of pulmonary disease in ataxia-telangiectasia.

Authors:  Sharon A McGrath-Morrow; W Adam Gower; Cynthia Rothblum-Oviatt; Alan S Brody; Claire Langston; Leland L Fan; Maureen A Lefton-Greif; Thomas O Crawford; Michelle Troche; John T Sandlund; Paul G Auwaerter; Blaine Easley; Gerald M Loughlin; John L Carroll; Howard M Lederman
Journal:  Pediatr Pulmonol       Date:  2010-09

2.  Safety and caregiver satisfaction with gastrostomy in patients with Ataxia Telangiectasia.

Authors:  Maureen A Lefton-Greif; Thomas O Crawford; Sharon McGrath-Morrow; Kathryn A Carson; Howard M Lederman
Journal:  Orphanet J Rare Dis       Date:  2011-05-15       Impact factor: 4.123

3.  Pulmonary function in children and young adults with ataxia telangiectasia.

Authors:  Sharon A McGrath-Morrow; Howard M Lederman; Angela D Aherrera; Maureen A Lefton-Greif; Thomas O Crawford; Timothy Ryan; Jennifer Wright; Joseph M Collaco
Journal:  Pediatr Pulmonol       Date:  2013-02-08

4.  Non invasive assessment of lung disease in ataxia telangiectasia by high-field magnetic resonance imaging.

Authors:  Silvia Montella; Carmine Mollica; Andrea Finocchi; Andrea Pession; Maria Cristina Pietrogrande; Antonino Trizzino; Giusy Ranucci; Marco Maglione; Giuliana Giardino; Marco Salvatore; Francesca Santamaria; Claudio Pignata
Journal:  J Clin Immunol       Date:  2013-08-24       Impact factor: 8.317

Review 5.  Ataxia telangiectasia: a review.

Authors:  Cynthia Rothblum-Oviatt; Jennifer Wright; Maureen A Lefton-Greif; Sharon A McGrath-Morrow; Thomas O Crawford; Howard M Lederman
Journal:  Orphanet J Rare Dis       Date:  2016-11-25       Impact factor: 4.123

Review 6.  Neurological and Sleep Disturbances in Bronchiectasis.

Authors:  Chun Seng Phua; Tissa Wijeratne; Conroy Wong; Lata Jayaram
Journal:  J Clin Med       Date:  2017-11-30       Impact factor: 4.241

7.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

Review 8.  Consensus Recommendations for the Clinical Management of Hematological Malignancies in Patients with DNA Double Stranded Break Disorders.

Authors:  Agata Pastorczak; Andishe Attarbaschi; Simon Bomken; Arndt Borkhardt; Jutte van der Werff Ten Bosch; Sarah Elitzur; Andrew R Gennery; Eva Hlavackova; Arpád Kerekes; Zdenka Křenová; Wojciech Mlynarski; Tomasz Szczepanski; Tessa Wassenberg; Jan Loeffen
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

9.  In vitro dexamethasone treatment does not induce alternative ATM transcripts in cells from Ataxia-Telangiectasia patients.

Authors:  Elisa Pozzi; Elisa Giorgio; Cecilia Mancini; Nicola Lo Buono; Stefania Augeri; Marta Ferrero; Eleonora Di Gregorio; Evelise Riberi; Maria Vinciguerra; Lorenzo Nanetti; Federico Tommaso Bianchi; Maria Paola Sassi; Vincenzo Costanzo; Caterina Mariotti; Ada Funaro; Simona Cavalieri; Alfredo Brusco
Journal:  Sci Rep       Date:  2020-11-19       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.